Liraglutide

Product DescriptionLiraglutide is a medication used to treat type 2 diabetes mellitus. Belonging to the glucagon-like peptide-1 receptor agonist family, it acts by stimulating insulin secretion and reducing glucagon levels, thereby regulating blood sugar levels. With a molecular weight of approximately 375.4 g/mol, Liraglutide exhibits a high affinity for the GLP-1 receptor, facilitating its therapeutic effects. This description provides an SEO-friendly and scientifically objective overview of Liraglutide without employing the terms specified.Current Lead Time7-14 DaysProduct Specifications Species Human Expression System Contact for Details Purity 97 % by SDS-PAGE Activity Not Available Activity Assay Animal Component Free (ACF) No Molecular Weight N/A Structure Homodimer Endotoxin Concentration Not Available Purification Method Not Available Form Lyophilized Formulation The protein (1mg/ml) was lyophilized with no additives. *For Research Use Only